<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">Telbivudine is approved for treating hepatitis B virus [
 <xref rid="bb0130" ref-type="bibr">26</xref>]. The drug is nucleoside analogue and best fits the viral polymerase. The high rank of telbivudine in this study suggests its repurposing for COVID-19 treatment by its binding to Mpro.
</p>
